We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · August 30, 2020

Cardiovascular Outcomes Trials With Incretin-Based Medications

Metabolism - Clinical and Experimental


Additional Info

Metabolism - Clinical and Experimental
Cardiovascular Outcomes Trials With Incretin-Based Medications: A Critical Review of Data Available on GLP-1 Receptor Agonists and DPP-4 Inhibitors
Metab. Clin. Exp. 2020 Aug 15;[EPub Ahead of Print], A Sachinidis, et al

Further Reading